Net Cash Provided by (Used in) Operating Activities |
-3.49M |
USD |
-52% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
8.33M |
USD |
+180% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
+400% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
3.22M |
shares |
-82.2% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.18M |
USD |
+8969% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
-100% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
25.6M |
USD |
+20.5% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
25.6M |
USD |
+20.5% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
21.9M |
USD |
+17.6% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
10M |
shares |
|
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
124M |
USD |
+43.4% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2022 |
FY 2022 |
Share-based Payment Arrangement, Expense |
41K |
USD |
-92.6% |
Q2 2024 |
Q2 2024 |
Interest Expense |
648K |
USD |
-30.2% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2024 |
Q2 2024 |